Traders bought shares of Danaher Corporation (NYSE:DHR) on weakness during trading hours on Monday. $47.42 million flowed into the stock on the tick-up and $20.83 million flowed out of the stock on the tick-down, for a money net flow of $26.59 million into the stock. Of all companies tracked, Danaher Corporation had the 26th highest net in-flow for the day. Danaher Corporation traded down ($0.51) for the day and closed at $92.62

A number of equities analysts have commented on DHR shares. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price objective on shares of Danaher Corporation in a research note on Friday, September 8th. Wells Fargo & Company restated a “market perform” rating on shares of Danaher Corporation in a research note on Saturday, July 22nd. Zacks Investment Research upgraded Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 price objective on the stock in a research note on Thursday, October 5th. Citigroup Inc. set a $96.00 price objective on Danaher Corporation and gave the stock a “buy” rating in a research note on Friday, July 21st. Finally, Morgan Stanley restated an “overweight” rating and set a $95.00 price objective (up previously from $86.00) on shares of Danaher Corporation in a research note on Friday, October 6th. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have assigned a buy rating and one has given a strong buy rating to the stock. Danaher Corporation has a consensus rating of “Buy” and a consensus target price of $93.31.

The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market cap of $64,330.00, a price-to-earnings ratio of 23.94, a price-to-earnings-growth ratio of 2.21 and a beta of 1.02.

Danaher Corporation (NYSE:DHR) last released its quarterly earnings data on Thursday, October 19th. The conglomerate reported $1.00 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.95 by $0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The company had revenue of $4.53 billion for the quarter, compared to the consensus estimate of $4.47 billion. During the same quarter last year, the business posted $0.87 EPS. Danaher Corporation’s revenue for the quarter was up 9.6% on a year-over-year basis. equities analysts forecast that Danaher Corporation will post 3.99 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Friday, October 27th. Investors of record on Friday, September 29th were issued a dividend of $0.14 per share. This represents a $0.56 annualized dividend and a dividend yield of 0.60%. The ex-dividend date of this dividend was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is 16.67%.

In related news, Director Donald J. Ehrlich sold 10,578 shares of the firm’s stock in a transaction on Tuesday, October 24th. The stock was sold at an average price of $90.82, for a total transaction of $960,693.96. Following the sale, the director now owns 104,621 shares of the company’s stock, valued at approximately $9,501,679.22. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CEO Thomas Patrick Joyce, Jr. sold 125,989 shares of the firm’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $92.64, for a total value of $11,671,620.96. Following the sale, the chief executive officer now directly owns 271,737 shares in the company, valued at approximately $25,173,715.68. The disclosure for this sale can be found here. In the last three months, insiders have sold 279,628 shares of company stock worth $25,304,394. 12.20% of the stock is currently owned by company insiders.

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DHR. Mason Street Advisors LLC lifted its holdings in Danaher Corporation by 1.3% during the 1st quarter. Mason Street Advisors LLC now owns 84,309 shares of the conglomerate’s stock worth $7,211,000 after buying an additional 1,042 shares during the period. Pacer Advisors Inc. lifted its holdings in Danaher Corporation by 3.3% during the 1st quarter. Pacer Advisors Inc. now owns 12,863 shares of the conglomerate’s stock worth $1,100,000 after buying an additional 407 shares during the period. Nordea Investment Management AB lifted its holdings in Danaher Corporation by 7.0% during the 1st quarter. Nordea Investment Management AB now owns 74,534 shares of the conglomerate’s stock worth $6,375,000 after buying an additional 4,898 shares during the period. Trust Co. of Toledo NA OH lifted its holdings in Danaher Corporation by 1.8% during the 1st quarter. Trust Co. of Toledo NA OH now owns 37,641 shares of the conglomerate’s stock worth $3,220,000 after buying an additional 673 shares during the period. Finally, Private Advisor Group LLC lifted its holdings in Danaher Corporation by 3.0% during the 1st quarter. Private Advisor Group LLC now owns 17,946 shares of the conglomerate’s stock worth $1,539,000 after buying an additional 525 shares during the period. 75.61% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: “Traders Buy Shares of Danaher Corporation (DHR) on Weakness” was published by Watch List News and is the property of of Watch List News. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://www.watchlistnews.com/traders-buy-shares-of-danaher-corporation-dhr-on-weakness/1683933.html.

Danaher Corporation Company Profile

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with Analyst Ratings Network's FREE daily email newsletter.